
### [MONDO:0000648](http://purl.obolibrary.org/obo/MONDO_0000648)
**Label:** nervous system benign neoplasm

**Subclasses:** [MONDO:0003925](http://purl.obolibrary.org/obo/MONDO_0003925) (ethmoid sinus inverted papilloma), [MONDO:0021476](http://purl.obolibrary.org/obo/MONDO_0021476) (benign neoplasm of tongue), [MONDO:0003926](http://purl.obolibrary.org/obo/MONDO_0003926) (neurilemmoma of the pleura), [MONDO:0021475](http://purl.obolibrary.org/obo/MONDO_0021475) (benign neoplasm of nasal cavity), [MONDO:0002559](http://purl.obolibrary.org/obo/MONDO_0002559) (plexiform schwannoma), [MONDO:0003923](http://purl.obolibrary.org/obo/MONDO_0003923) (ethmoid sinus Schneiderian papilloma), [MONDO:0015196](http://purl.obolibrary.org/obo/MONDO_0015196) (vein of Galen aneurysm), [MONDO:0021477](http://purl.obolibrary.org/obo/MONDO_0021477) (benign neoplasm of sphenoidal sinus), [MONDO:0002556](http://purl.obolibrary.org/obo/MONDO_0002556) (macrocystic neurilemmoma), [MONDO:0002555](http://purl.obolibrary.org/obo/MONDO_0002555) (neurilemmoma of the fifth cranial nerve), [MONDO:0021515](http://purl.obolibrary.org/obo/MONDO_0021515) (benign neoplasm of ethmoidal sinus), [MONDO:0002712](http://purl.obolibrary.org/obo/MONDO_0002712) (epidural spinal canal angiolipoma), [MONDO:0002558](http://purl.obolibrary.org/obo/MONDO_0002558) (melanotic neurilemmoma), [MONDO:0006634](http://purl.obolibrary.org/obo/MONDO_0006634) (pituitary gland acidophil adenoma), [MONDO:0004457](http://purl.obolibrary.org/obo/MONDO_0004457) (maxillary sinus Schneiderian papilloma), [MONDO:0006238](http://purl.obolibrary.org/obo/MONDO_0006238) (growth hormone-producing pituitary gland adenoma), [MONDO:0002554](http://purl.obolibrary.org/obo/MONDO_0002554) (sympathetic neurilemmoma), [MONDO:0003241](http://purl.obolibrary.org/obo/MONDO_0003241) (central nervous system hemangioma), [MONDO:0007566](http://purl.obolibrary.org/obo/MONDO_0007566) (multiple self-healing squamous epithelioma), [MONDO:0021474](http://purl.obolibrary.org/obo/MONDO_0021474) (benign neoplasm of ear), [MONDO:0006353](http://purl.obolibrary.org/obo/MONDO_0006353) (paranasal sinus Schneiderian papilloma), [MONDO:0018907](http://purl.obolibrary.org/obo/MONDO_0018907) (craniopharyngioma), [MONDO:0010621](http://purl.obolibrary.org/obo/MONDO_0010621) (child syndrome), [MONDO:0016723](http://purl.obolibrary.org/obo/MONDO_0016723) (pineocytoma (disease)), [MONDO:0021627](http://purl.obolibrary.org/obo/MONDO_0021627) (eyelid capillary hemangioma), [MONDO:0021506](http://purl.obolibrary.org/obo/MONDO_0021506) (benign neoplasm of spinal cord), [MONDO:0021507](http://purl.obolibrary.org/obo/MONDO_0021507) (benign neoplasm of brain stem), [MONDO:0008097](http://purl.obolibrary.org/obo/MONDO_0008097) (linear nevus sebaceus syndrome), [MONDO:0016035](http://purl.obolibrary.org/obo/MONDO_0016035) (Nelson syndrome), [MONDO:0000821](http://purl.obolibrary.org/obo/MONDO_0000821) (cerebral cavernous malformation 3), [MONDO:0002328](http://purl.obolibrary.org/obo/MONDO_0002328) (intracranial hemangioma), [MONDO:0009227](http://purl.obolibrary.org/obo/MONDO_0009227) (myofibromatosis, infantile, 1), [MONDO:0008018](http://purl.obolibrary.org/obo/MONDO_0008018) (Muir-Torre syndrome), [MONDO:0002327](http://purl.obolibrary.org/obo/MONDO_0002327) (intracranial cavernous angioma), [MONDO:0000820](http://purl.obolibrary.org/obo/MONDO_0000820) (cerebral cavernous malformation), [MONDO:0003894](http://purl.obolibrary.org/obo/MONDO_0003894) (mediastinal melanocytic neurilemmoma), [MONDO:0006366](http://purl.obolibrary.org/obo/MONDO_0006366) (Peutz-Jeghers polyp of the stomach), [MONDO:0003254](http://purl.obolibrary.org/obo/MONDO_0003254) (cardiac granular cell neoplasm), [MONDO:0003250](http://purl.obolibrary.org/obo/MONDO_0003250) (benign granular cell tumor), [MONDO:0007052](http://purl.obolibrary.org/obo/MONDO_0007052) (growth hormone secreting pituitary adenoma), [MONDO:0011305](http://purl.obolibrary.org/obo/MONDO_0011305) (cerebral cavernous malformations 3), [MONDO:0007291](http://purl.obolibrary.org/obo/MONDO_0007291) (familial cerebral cavernous malformation), [MONDO:0011304](http://purl.obolibrary.org/obo/MONDO_0011304) (cerebral cavernous malformation 2), [MONDO:0019933](http://purl.obolibrary.org/obo/MONDO_0019933) (acromegaly), [MONDO:0000638](http://purl.obolibrary.org/obo/MONDO_0000638) (benign glioma), [MONDO:0014122](http://purl.obolibrary.org/obo/MONDO_0014122) (myofibromatosis, infantile, 2), [MONDO:0021454](http://purl.obolibrary.org/obo/MONDO_0021454) (benign neoplasm of eye), [MONDO:0021453](http://purl.obolibrary.org/obo/MONDO_0021453) (benign neoplasm of retina), [MONDO:0001569](http://purl.obolibrary.org/obo/MONDO_0001569) (acoustic neuroma), [MONDO:0001723](http://purl.obolibrary.org/obo/MONDO_0001723) (progressive peripheral pterygium), [MONDO:0003901](http://purl.obolibrary.org/obo/MONDO_0003901) (cerebellar hemangioblastoma), [MONDO:0009578](http://purl.obolibrary.org/obo/MONDO_0009578) (neurocutaneous melanocytosis), [MONDO:0003902](http://purl.obolibrary.org/obo/MONDO_0003902) (brain stem hemangioblastoma), [MONDO:0001722](http://purl.obolibrary.org/obo/MONDO_0001722) (central pterygium), [MONDO:0000633](http://purl.obolibrary.org/obo/MONDO_0000633) (sensory organ benign neoplasm), [MONDO:0003343](http://purl.obolibrary.org/obo/MONDO_0003343) (retinal hemangioblastoma), [MONDO:0007667](http://purl.obolibrary.org/obo/MONDO_0007667) (subependymoma), [MONDO:0004397](http://purl.obolibrary.org/obo/MONDO_0004397) (benign mediastinal psammomatous neurilemmoma), [MONDO:0004398](http://purl.obolibrary.org/obo/MONDO_0004398) (mediastinal schwannoma), [MONDO:0003980](http://purl.obolibrary.org/obo/MONDO_0003980) (schwannoma of jugular foramen), [MONDO:0021452](http://purl.obolibrary.org/obo/MONDO_0021452) (benign neoplasm of cornea), [MONDO:0021451](http://purl.obolibrary.org/obo/MONDO_0021451) (benign neoplasm of brain), [MONDO:0005085](http://purl.obolibrary.org/obo/MONDO_0005085) (pterygium), [MONDO:0006172](http://purl.obolibrary.org/obo/MONDO_0006172) (conjunctival nevus), [MONDO:0016824](http://purl.obolibrary.org/obo/MONDO_0016824) (myofibromatosis), [MONDO:0021605](http://purl.obolibrary.org/obo/MONDO_0021605) (benign eyelid neoplasm), [MONDO:0012691](http://purl.obolibrary.org/obo/MONDO_0012691) (leopard syndrome 2), [MONDO:0008075](http://purl.obolibrary.org/obo/MONDO_0008075) (neurofibromatosis type 3), [MONDO:0002549](http://purl.obolibrary.org/obo/MONDO_0002549) (schwannoma of twelfth cranial nerve), [MONDO:0002548](http://purl.obolibrary.org/obo/MONDO_0002548) (cellular schwannoma), [MONDO:0013380](http://purl.obolibrary.org/obo/MONDO_0013380) (leopard syndrome 3), [MONDO:0002787](http://purl.obolibrary.org/obo/MONDO_0002787) (adamantinous craniopharyngioma), [MONDO:0020479](http://purl.obolibrary.org/obo/MONDO_0020479) (pituitary gigantism), [MONDO:0004326](http://purl.obolibrary.org/obo/MONDO_0004326) (sphenoid sinus inverted papilloma), [MONDO:0002546](http://purl.obolibrary.org/obo/MONDO_0002546) (schwannoma), [MONDO:0004327](http://purl.obolibrary.org/obo/MONDO_0004327) (sphenoid sinus Schneiderian papilloma), [MONDO:0004448](http://purl.obolibrary.org/obo/MONDO_0004448) (frontal sinus inverted papilloma), [MONDO:0002788](http://purl.obolibrary.org/obo/MONDO_0002788) (papillary craniopharyngioma), [MONDO:0021281](http://purl.obolibrary.org/obo/MONDO_0021281) (cavernous hemangioma of retina), [MONDO:0003752](http://purl.obolibrary.org/obo/MONDO_0003752) (frontal sinus Schneiderian papilloma), [MONDO:0003753](http://purl.obolibrary.org/obo/MONDO_0003753) (nasal vestibule squamous papilloma), [MONDO:0001055](http://purl.obolibrary.org/obo/MONDO_0001055) (conjunctival pterygium), [MONDO:0006105](http://purl.obolibrary.org/obo/MONDO_0006105) (benign conjunctival neoplasm), [MONDO:0003476](http://purl.obolibrary.org/obo/MONDO_0003476) (clear cell ependymoma), [MONDO:0006104](http://purl.obolibrary.org/obo/MONDO_0006104) (benign carotid body paraganglioma), [MONDO:0006103](http://purl.obolibrary.org/obo/MONDO_0006103) (benign adrenal gland pheochromocytoma), [MONDO:0001054](http://purl.obolibrary.org/obo/MONDO_0001054) (double pterygium), [MONDO:0006068](http://purl.obolibrary.org/obo/MONDO_0006068) (ACTH-producing pituitary gland adenoma), [MONDO:0007154](http://purl.obolibrary.org/obo/MONDO_0007154) (arteriovenous malformations of the brain), [MONDO:0003470](http://purl.obolibrary.org/obo/MONDO_0003470) (cellular ependymoma), [MONDO:0019927](http://purl.obolibrary.org/obo/MONDO_0019927) (growth hormone-producing pituitary gland neoplasm), [MONDO:0008080](http://purl.obolibrary.org/obo/MONDO_0008080) (neurofibromatosis, type III, mixed central and peripheral), [MONDO:0009050](http://purl.obolibrary.org/obo/MONDO_0009050) (ACTH-secreting pituitary adenoma), [MONDO:0021439](http://purl.obolibrary.org/obo/MONDO_0021439) (benign neoplasm of pituitary gland), [MONDO:0004818](http://purl.obolibrary.org/obo/MONDO_0004818) (benign neurilemmoma), [MONDO:0003844](http://purl.obolibrary.org/obo/MONDO_0003844) (central nervous system lipoma), [MONDO:0003845](http://purl.obolibrary.org/obo/MONDO_0003845) (corpus callosum lipoma), [MONDO:0019196](http://purl.obolibrary.org/obo/MONDO_0019196) (Foix-Alajouanine syndrome), [MONDO:0000973](http://purl.obolibrary.org/obo/MONDO_0000973) (external ear lipoma), [MONDO:0003843](http://purl.obolibrary.org/obo/MONDO_0003843) (cerebral hemisphere lipoma), [MONDO:0009837](http://purl.obolibrary.org/obo/MONDO_0009837) (choroid plexus papilloma), [MONDO:0004133](http://purl.obolibrary.org/obo/MONDO_0004133) (pituitary gland mixed eosinophil-basophil adenoma), [MONDO:0021273](http://purl.obolibrary.org/obo/MONDO_0021273) (leiomyoma of ciliary body), [MONDO:0006673](http://purl.obolibrary.org/obo/MONDO_0006673) (pituitary gland basophil adenoma), [MONDO:0003287](http://purl.obolibrary.org/obo/MONDO_0003287) (central nervous system leiomyoma), [MONDO:0021275](http://purl.obolibrary.org/obo/MONDO_0021275) (papilloma of eyelid), [MONDO:0003161](http://purl.obolibrary.org/obo/MONDO_0003161) (benign ependymoma), [MONDO:0002072](http://purl.obolibrary.org/obo/MONDO_0002072) (melanotic neuroectodermal tumor), [MONDO:0014299](http://purl.obolibrary.org/obo/MONDO_0014299) (Schwannomatosis 2), [MONDO:0010492](http://purl.obolibrary.org/obo/MONDO_0010492) (pituitary adenoma, growth hormone-secreting, 2), [MONDO:0016754](http://purl.obolibrary.org/obo/MONDO_0016754) (vestibular schwannoma (disease)), [MONDO:0000628](http://purl.obolibrary.org/obo/MONDO_0000628) (central nervous system organ benign neoplasm), [MONDO:0018893](http://purl.obolibrary.org/obo/MONDO_0018893) (Cobb syndrome), [MONDO:0021542](http://purl.obolibrary.org/obo/MONDO_0021542) (hemangioma of choroid), [MONDO:0018892](http://purl.obolibrary.org/obo/MONDO_0018892) (Wyburn-Mason syndrome), [MONDO:0020178](http://purl.obolibrary.org/obo/MONDO_0020178) (palpebral lentiginosis), [MONDO:0021541](http://purl.obolibrary.org/obo/MONDO_0021541) (hemangioma of retina), [MONDO:0020179](http://purl.obolibrary.org/obo/MONDO_0020179) (palpebral nevus), [MONDO:0004820](http://purl.obolibrary.org/obo/MONDO_0004820) (peripheral nerve schwannoma), [MONDO:0003054](http://purl.obolibrary.org/obo/MONDO_0003054) (benign meningioma), [MONDO:0020173](http://purl.obolibrary.org/obo/MONDO_0020173) (benign tumor of palpebral epidermis), [MONDO:0004384](http://purl.obolibrary.org/obo/MONDO_0004384) (maxillary sinus inverted papilloma), [MONDO:0001790](http://purl.obolibrary.org/obo/MONDO_0001790) (spinal cord lipoma), [MONDO:0007893](http://purl.obolibrary.org/obo/MONDO_0007893) (Noonan syndrome with multiple lentigines), [MONDO:0019612](http://purl.obolibrary.org/obo/MONDO_0019612) (functioning gonadotropic adenoma), [MONDO:0019613](http://purl.obolibrary.org/obo/MONDO_0019613) (non-functioning pituitary adenoma), [MONDO:0019611](http://purl.obolibrary.org/obo/MONDO_0019611) (TSH-secreting pituitary adenoma), [MONDO:0003828](http://purl.obolibrary.org/obo/MONDO_0003828) (growth hormone-producing pituitary gland carcinoma), [MONDO:0019972](http://purl.obolibrary.org/obo/MONDO_0019972) (dural sinus malformation), [MONDO:0003948](http://purl.obolibrary.org/obo/MONDO_0003948) (cerebral hemangioma), [MONDO:0007907](http://purl.obolibrary.org/obo/MONDO_0007907) (lipoma of the conjunctiva), [MONDO:0021497](http://purl.obolibrary.org/obo/MONDO_0021497) (benign neoplasm of cerebrum), [MONDO:0003428](http://purl.obolibrary.org/obo/MONDO_0003428) (brain hemangioma), [MONDO:0003307](http://purl.obolibrary.org/obo/MONDO_0003307) (multiple mucosal neuroma), [MONDO:0021499](http://purl.obolibrary.org/obo/MONDO_0021499) (benign neoplasm of cerebellum), [MONDO:0003429](http://purl.obolibrary.org/obo/MONDO_0003429) (functioning pituitary gland adenoma), [MONDO:0003943](http://purl.obolibrary.org/obo/MONDO_0003943) (central nervous system hibernoma), [MONDO:0001400](http://purl.obolibrary.org/obo/MONDO_0001400) (schwannoma of ureter), [MONDO:0003423](http://purl.obolibrary.org/obo/MONDO_0003423) (middle ear adenoma), [MONDO:0002173](http://purl.obolibrary.org/obo/MONDO_0002173) (neuroma), [MONDO:0006373](http://purl.obolibrary.org/obo/MONDO_0006373) (pituitary gland adenoma), [MONDO:0016748](http://purl.obolibrary.org/obo/MONDO_0016748) (hemangioblastoma), [MONDO:0021527](http://purl.obolibrary.org/obo/MONDO_0021527) (benign neoplasm of meninges), [MONDO:0017822](http://purl.obolibrary.org/obo/MONDO_0017822) (mixed functioning pituitary adenoma), [MONDO:0018115](http://purl.obolibrary.org/obo/MONDO_0018115) (epidermal nevus syndrome), [MONDO:0016693](http://purl.obolibrary.org/obo/MONDO_0016693) (subependymal giant cell astrocytoma), [MONDO:0021487](http://purl.obolibrary.org/obo/MONDO_0021487) (benign neoplasm of choroid), [MONDO:0003837](http://purl.obolibrary.org/obo/MONDO_0003837) (TSH producing pituitary tumor), [MONDO:0021486](http://purl.obolibrary.org/obo/MONDO_0021486) (benign neoplasm of ciliary body), [MONDO:0021488](http://purl.obolibrary.org/obo/MONDO_0021488) (benign neoplasm of lacrimal gland), [MONDO:0003836](http://purl.obolibrary.org/obo/MONDO_0003836) (malignant thyroid stimulating hormone producing neoplasm of pituitary gland), [MONDO:0006701](http://purl.obolibrary.org/obo/MONDO_0006701) (chromophobe adenoma), [MONDO:0021483](http://purl.obolibrary.org/obo/MONDO_0021483) (benign neoplasm of frontal sinus), [MONDO:0021482](http://purl.obolibrary.org/obo/MONDO_0021482) (benign neoplasm of middle ear), [MONDO:0021485](http://purl.obolibrary.org/obo/MONDO_0021485) (benign neoplasm of iris), [MONDO:0021484](http://purl.obolibrary.org/obo/MONDO_0021484) (benign neoplasm of maxillary sinus), [MONDO:0003154](http://purl.obolibrary.org/obo/MONDO_0003154) (hemangioma of peripheral nerve), [MONDO:0015407](http://purl.obolibrary.org/obo/MONDO_0015407) (cerebrofacial arteriovenous metameric syndrome type 3), [MONDO:0017824](http://purl.obolibrary.org/obo/MONDO_0017824) (familial isolated pituitary adenoma), [MONDO:0010911](http://purl.obolibrary.org/obo/MONDO_0010911) (prolactin-producing pituitary gland adenoma), [MONDO:0017823](http://purl.obolibrary.org/obo/MONDO_0017823) (Somatomammotropinoma), [MONDO:0017826](http://purl.obolibrary.org/obo/MONDO_0017826) (null pituitary adenoma), [MONDO:0015406](http://purl.obolibrary.org/obo/MONDO_0015406) (cerebrofacial arteriovenous metameric syndrome type 1), [MONDO:0015405](http://purl.obolibrary.org/obo/MONDO_0015405) (cerebrofacial arteriovenous metameric syndrome), [MONDO:0008280](http://purl.obolibrary.org/obo/MONDO_0008280) (Peutz-Jeghers syndrome), [MONDO:0017825](http://purl.obolibrary.org/obo/MONDO_0017825) (silent pituitary adenoma), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0060125](http://purl.obolibrary.org/obo/GO_0060125) (negative regulation of growth hormone secretion), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0003697](http://purl.obolibrary.org/obo/GO_0003697) (single-stranded DNA binding), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0050431](http://purl.obolibrary.org/obo/GO_0050431) (transforming growth factor beta binding), [GO:0000187](http://purl.obolibrary.org/obo/GO_0000187) (activation of MAPK activity), [GO:0050793](http://purl.obolibrary.org/obo/GO_0050793) (regulation of developmental process), [GO:0000186](http://purl.obolibrary.org/obo/GO_0000186) (activation of MAPKK activity), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0072223](http://purl.obolibrary.org/obo/GO_0072223) (metanephric glomerular mesangium development), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:2000352](http://purl.obolibrary.org/obo/GO_2000352) (negative regulation of endothelial cell apoptotic process), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:2000114](http://purl.obolibrary.org/obo/GO_2000114) (regulation of establishment of cell polarity), [GO:2000491](http://purl.obolibrary.org/obo/GO_2000491) (positive regulation of hepatic stellate cell activation), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:2000251](http://purl.obolibrary.org/obo/GO_2000251) (positive regulation of actin cytoskeleton reorganization), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:1900029](http://purl.obolibrary.org/obo/GO_1900029) (positive regulation of ruffle assembly), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0004675](http://purl.obolibrary.org/obo/GO_0004675) (transmembrane receptor protein serine/threonine kinase activity), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0048011](http://purl.obolibrary.org/obo/GO_0048011) (neurotrophin TRK receptor signaling pathway), [GO:0071480](http://purl.obolibrary.org/obo/GO_0071480) (cellular response to gamma radiation), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus), [GO:0035022](http://purl.obolibrary.org/obo/GO_0035022) (positive regulation of Rac protein signal transduction), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0035265](http://purl.obolibrary.org/obo/GO_0035265) (organ growth), [GO:0035025](http://purl.obolibrary.org/obo/GO_0035025) (positive regulation of Rho protein signal transduction), [GO:0060020](http://purl.obolibrary.org/obo/GO_0060020) (Bergmann glial cell differentiation), [GO:0048259](http://purl.obolibrary.org/obo/GO_0048259) (regulation of receptor-mediated endocytosis), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0060028](http://purl.obolibrary.org/obo/GO_0060028) (convergent extension involved in axis elongation), [GO:0042832](http://purl.obolibrary.org/obo/GO_0042832) (defense response to protozoan), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0035019](http://purl.obolibrary.org/obo/GO_0035019) (somatic stem cell population maintenance), [GO:0051428](http://purl.obolibrary.org/obo/GO_0051428) (peptide hormone receptor binding), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0016616](http://purl.obolibrary.org/obo/GO_0016616) (oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor), [GO:0061582](http://purl.obolibrary.org/obo/GO_0061582) (intestinal epithelial cell migration), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0071260](http://purl.obolibrary.org/obo/GO_0071260) (cellular response to mechanical stimulus), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0036459](http://purl.obolibrary.org/obo/GO_0036459) (thiol-dependent ubiquitinyl hydrolase activity), [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0019838](http://purl.obolibrary.org/obo/GO_0019838) (growth factor binding), [GO:0036297](http://purl.obolibrary.org/obo/GO_0036297) (interstrand cross-link repair), [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0005546](http://purl.obolibrary.org/obo/GO_0005546) (phosphatidylinositol-4,5-bisphosphate binding), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0045177](http://purl.obolibrary.org/obo/GO_0045177) (apical part of cell), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0045296](http://purl.obolibrary.org/obo/GO_0045296) (cadherin binding), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0030983](http://purl.obolibrary.org/obo/GO_0030983) (mismatched DNA binding), [GO:0030864](http://purl.obolibrary.org/obo/GO_0030864) (cortical actin cytoskeleton), [GO:0014037](http://purl.obolibrary.org/obo/GO_0014037) (Schwann cell differentiation), [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth), [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development), [GO:0006897](http://purl.obolibrary.org/obo/GO_0006897) (endocytosis), [GO:0003146](http://purl.obolibrary.org/obo/GO_0003146) (heart jogging), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0050768](http://purl.obolibrary.org/obo/GO_0050768) (negative regulation of neurogenesis), [GO:0050767](http://purl.obolibrary.org/obo/GO_0050767) (regulation of neurogenesis), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0016446](http://purl.obolibrary.org/obo/GO_0016446) (somatic hypermutation of immunoglobulin genes), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:2001275](http://purl.obolibrary.org/obo/GO_2001275) (positive regulation of glucose import in response to insulin stimulus), [GO:0060347](http://purl.obolibrary.org/obo/GO_0060347) (heart trabecula formation), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0047012](http://purl.obolibrary.org/obo/GO_0047012) (sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:2000177](http://purl.obolibrary.org/obo/GO_2000177) (regulation of neural precursor cell proliferation), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0045190](http://purl.obolibrary.org/obo/GO_0045190) (isotype switching), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0014013](http://purl.obolibrary.org/obo/GO_0014013) (regulation of gliogenesis), [GO:0060696](http://purl.obolibrary.org/obo/GO_0060696) (regulation of phospholipid catabolic process), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0060575](http://purl.obolibrary.org/obo/GO_0060575) (intestinal epithelial cell differentiation), [GO:0014010](http://purl.obolibrary.org/obo/GO_0014010) (Schwann cell proliferation), [GO:0004450](http://purl.obolibrary.org/obo/GO_0004450) (isocitrate dehydrogenase (NADP+) activity), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0005777](http://purl.obolibrary.org/obo/GO_0005777) (peroxisome), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0004448](http://purl.obolibrary.org/obo/GO_0004448) (isocitrate dehydrogenase activity), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0072554](http://purl.obolibrary.org/obo/GO_0072554) (blood vessel lumenization), [GO:0051990](http://purl.obolibrary.org/obo/GO_0051990) ((R)-2-hydroxyglutarate dehydrogenase activity), [GO:0006749](http://purl.obolibrary.org/obo/GO_0006749) (glutathione metabolic process), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:0061056](http://purl.obolibrary.org/obo/GO_0061056) (sclerotome development), [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0042532](http://purl.obolibrary.org/obo/GO_0042532) (negative regulation of tyrosine phosphorylation of STAT protein), [GO:0007413](http://purl.obolibrary.org/obo/GO_0007413) (axonal fasciculation), [GO:0009948](http://purl.obolibrary.org/obo/GO_0009948) (anterior/posterior axis specification), [GO:0032967](http://purl.obolibrary.org/obo/GO_0032967) (positive regulation of collagen biosynthetic process), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0030308](http://purl.obolibrary.org/obo/GO_0030308) (negative regulation of cell growth), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0032729](http://purl.obolibrary.org/obo/GO_0032729) (positive regulation of interferon-gamma production), [GO:0097009](http://purl.obolibrary.org/obo/GO_0097009) (energy homeostasis), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0006696](http://purl.obolibrary.org/obo/GO_0006696) (ergosterol biosynthetic process), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0014070](http://purl.obolibrary.org/obo/GO_0014070) (response to organic cyclic compound), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0009967](http://purl.obolibrary.org/obo/GO_0009967) (positive regulation of signal transduction), [GO:0006337](http://purl.obolibrary.org/obo/GO_0006337) (nucleosome disassembly), [GO:0045931](http://purl.obolibrary.org/obo/GO_0045931) (positive regulation of mitotic cell cycle), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0032956](http://purl.obolibrary.org/obo/GO_0032956) (regulation of actin cytoskeleton organization), [GO:0051496](http://purl.obolibrary.org/obo/GO_0051496) (positive regulation of stress fiber assembly), [GO:0016126](http://purl.obolibrary.org/obo/GO_0016126) (sterol biosynthetic process), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0014044](http://purl.obolibrary.org/obo/GO_0014044) (Schwann cell development), [GO:0043409](http://purl.obolibrary.org/obo/GO_0043409) (negative regulation of MAPK cascade), [GO:0072091](http://purl.obolibrary.org/obo/GO_0072091) (regulation of stem cell proliferation), [GO:0042552](http://purl.obolibrary.org/obo/GO_0042552) (myelination), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0006301](http://purl.obolibrary.org/obo/GO_0006301) (postreplication repair), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0006302](http://purl.obolibrary.org/obo/GO_0006302) (double-strand break repair), [GO:0051026](http://purl.obolibrary.org/obo/GO_0051026) (chiasma assembly), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0051146](http://purl.obolibrary.org/obo/GO_0051146) (striated muscle cell differentiation), [GO:0006537](http://purl.obolibrary.org/obo/GO_0006537) (glutamate biosynthetic process), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0038127](http://purl.obolibrary.org/obo/GO_0038127) (ERBB signaling pathway), [GO:0038002](http://purl.obolibrary.org/obo/GO_0038002) (endocrine signaling), [GO:0006310](http://purl.obolibrary.org/obo/GO_0006310) (DNA recombination), [GO:0006311](http://purl.obolibrary.org/obo/GO_0006311) (meiotic gene conversion), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0043531](http://purl.obolibrary.org/obo/GO_0043531) (ADP binding), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0042445](http://purl.obolibrary.org/obo/GO_0042445) (hormone metabolic process), [GO:0006312](http://purl.obolibrary.org/obo/GO_0006312) (mitotic recombination), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0060047](http://purl.obolibrary.org/obo/GO_0060047) (heart contraction), [GO:0008542](http://purl.obolibrary.org/obo/GO_0008542) (visual learning), [GO:0021514](http://purl.obolibrary.org/obo/GO_0021514) (ventral spinal cord interneuron differentiation), [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0009755](http://purl.obolibrary.org/obo/GO_0009755) (hormone-mediated signaling pathway), [GO:0032407](http://purl.obolibrary.org/obo/GO_0032407) (MutSalpha complex binding), [GO:0032528](http://purl.obolibrary.org/obo/GO_0032528) (microvillus organization), [GO:0072262](http://purl.obolibrary.org/obo/GO_0072262) (metanephric glomerular mesangial cell proliferation involved in metanephros development), [GO:0032405](http://purl.obolibrary.org/obo/GO_0032405) (MutLalpha complex binding), [GO:0048169](http://purl.obolibrary.org/obo/GO_0048169) (regulation of long-term neuronal synaptic plasticity), [GO:0030220](http://purl.obolibrary.org/obo/GO_0030220) (platelet formation), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0030466](http://purl.obolibrary.org/obo/GO_0030466) (chromatin silencing at silent mating-type cassette), [GO:0031434](http://purl.obolibrary.org/obo/GO_0031434) (mitogen-activated protein kinase kinase binding), [GO:0031313](http://purl.obolibrary.org/obo/GO_0031313) (extrinsic component of endosome membrane), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0021865](http://purl.obolibrary.org/obo/GO_0021865) (symmetric radial glial cell division in forebrain), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0060039](http://purl.obolibrary.org/obo/GO_0060039) (pericardium development), [GO:0035907](http://purl.obolibrary.org/obo/GO_0035907) (dorsal aorta development), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0035909](http://purl.obolibrary.org/obo/GO_0035909) (aorta morphogenesis), [GO:0032516](http://purl.obolibrary.org/obo/GO_0032516) (positive regulation of phosphoprotein phosphatase activity), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0010863](http://purl.obolibrary.org/obo/GO_0010863) (positive regulation of phospholipase C activity), [GO:0030695](http://purl.obolibrary.org/obo/GO_0030695) (GTPase regulator activity), [GO:0018105](http://purl.obolibrary.org/obo/GO_0018105) (peptidyl-serine phosphorylation), [GO:1900180](http://purl.obolibrary.org/obo/GO_1900180) (regulation of protein localization to nucleus), [GO:0018107](http://purl.obolibrary.org/obo/GO_0018107) (peptidyl-threonine phosphorylation), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0061154](http://purl.obolibrary.org/obo/GO_0061154) (endothelial tube morphogenesis), [GO:0006102](http://purl.obolibrary.org/obo/GO_0006102) (isocitrate metabolic process), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0006469](http://purl.obolibrary.org/obo/GO_0006469) (negative regulation of protein kinase activity), [GO:0005017](http://purl.obolibrary.org/obo/GO_0005017) (platelet-derived growth factor-activated receptor activity), [GO:0006103](http://purl.obolibrary.org/obo/GO_0006103) (2-oxoglutarate metabolic process), [GO:0005138](http://purl.obolibrary.org/obo/GO_0005138) (interleukin-6 receptor binding), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0009968](http://purl.obolibrary.org/obo/GO_0009968) (negative regulation of signal transduction), [GO:0051463](http://purl.obolibrary.org/obo/GO_0051463) (negative regulation of cortisol secretion), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity), [GO:0071071](http://purl.obolibrary.org/obo/GO_0071071) (regulation of phospholipid biosynthetic process), [GO:0007569](http://purl.obolibrary.org/obo/GO_0007569) (cell aging), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0042645](http://purl.obolibrary.org/obo/GO_0042645) (mitochondrial nucleoid), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0005019](http://purl.obolibrary.org/obo/GO_0005019) (platelet-derived growth factor beta-receptor activity), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0072277](http://purl.obolibrary.org/obo/GO_0072277) (metanephric glomerular capillary formation), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0048919](http://purl.obolibrary.org/obo/GO_0048919) (posterior lateral line neuromast development), [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0005070](http://purl.obolibrary.org/obo/GO_0005070) (SH3/SH2 adaptor activity), [GO:0022408](http://purl.obolibrary.org/obo/GO_0022408) (negative regulation of cell-cell adhesion), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000735](http://purl.obolibrary.org/obo/GO_0000735) (removal of nonhomologous ends), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0048914](http://purl.obolibrary.org/obo/GO_0048914) (myelination of anterior lateral line nerve axons), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0000980](http://purl.obolibrary.org/obo/GO_0000980) (RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0019003](http://purl.obolibrary.org/obo/GO_0019003) (GDP binding), [GO:0019002](http://purl.obolibrary.org/obo/GO_0019002) (GMP binding), [GO:0031234](http://purl.obolibrary.org/obo/GO_0031234) (extrinsic component of cytoplasmic side of plasma membrane), [GO:0001707](http://purl.obolibrary.org/obo/GO_0001707) (mesoderm formation), [GO:0030027](http://purl.obolibrary.org/obo/GO_0030027) (lamellipodium), [GO:0048806](http://purl.obolibrary.org/obo/GO_0048806) (genitalia development), [GO:0007264](http://purl.obolibrary.org/obo/GO_0007264) (small GTPase mediated signal transduction), [GO:0007141](http://purl.obolibrary.org/obo/GO_0007141) (male meiosis I), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0043111](http://purl.obolibrary.org/obo/GO_0043111) (replication fork arrest), [GO:0007265](http://purl.obolibrary.org/obo/GO_0007265) (Ras protein signal transduction), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0006298](http://purl.obolibrary.org/obo/GO_0006298) (mismatch repair), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0001837](http://purl.obolibrary.org/obo/GO_0001837) (epithelial to mesenchymal transition), [GO:0031226](http://purl.obolibrary.org/obo/GO_0031226) (intrinsic component of plasma membrane), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0006024](http://purl.obolibrary.org/obo/GO_0006024) (glycosaminoglycan biosynthetic process), [GO:0021654](http://purl.obolibrary.org/obo/GO_0021654) (rhombomere boundary formation), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0021897](http://purl.obolibrary.org/obo/GO_0021897) (forebrain astrocyte development), [GO:0048932](http://purl.obolibrary.org/obo/GO_0048932) (myelination of posterior lateral line nerve axons), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0005057](http://purl.obolibrary.org/obo/GO_0005057) (signal transducer activity, downstream of receptor), [GO:0005178](http://purl.obolibrary.org/obo/GO_0005178) (integrin binding), [GO:0000710](http://purl.obolibrary.org/obo/GO_0000710) (meiotic mismatch repair), [GO:0038091](http://purl.obolibrary.org/obo/GO_0038091) (positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway), [GO:0048936](http://purl.obolibrary.org/obo/GO_0048936) (peripheral nervous system neuron axonogenesis), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:0060947](http://purl.obolibrary.org/obo/GO_0060947) (cardiac vascular smooth muscle cell differentiation), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0032300](http://purl.obolibrary.org/obo/GO_0032300) (mismatch repair complex), [GO:0032301](http://purl.obolibrary.org/obo/GO_0032301) (MutSalpha complex), [GO:1990429](http://purl.obolibrary.org/obo/GO_1990429) (peroxisomal importomer complex), [GO:0031573](http://purl.obolibrary.org/obo/GO_0031573) (intra-S DNA damage checkpoint), [GO:0032302](http://purl.obolibrary.org/obo/GO_0032302) (MutSbeta complex), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0046887](http://purl.obolibrary.org/obo/GO_0046887) (positive regulation of hormone secretion), [GO:0043254](http://purl.obolibrary.org/obo/GO_0043254) (regulation of protein complex assembly), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0021766](http://purl.obolibrary.org/obo/GO_0021766) (hippocampus development), [GO:0038085](http://purl.obolibrary.org/obo/GO_0038085) (vascular endothelial growth factor binding), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0046888](http://purl.obolibrary.org/obo/GO_0046888) (negative regulation of hormone secretion), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0033629](http://purl.obolibrary.org/obo/GO_0033629) (negative regulation of cell adhesion mediated by integrin), [GO:0033628](http://purl.obolibrary.org/obo/GO_0033628) (regulation of cell adhesion mediated by integrin), [GO:0001932](http://purl.obolibrary.org/obo/GO_0001932) (regulation of protein phosphorylation), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0001937](http://purl.obolibrary.org/obo/GO_0001937) (negative regulation of endothelial cell proliferation), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0007173](http://purl.obolibrary.org/obo/GO_0007173) (epidermal growth factor receptor signaling pathway), [GO:0007059](http://purl.obolibrary.org/obo/GO_0007059) (chromosome segregation), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0043547](http://purl.obolibrary.org/obo/GO_0043547) (positive regulation of GTPase activity), [GO:0045602](http://purl.obolibrary.org/obo/GO_0045602) (negative regulation of endothelial cell differentiation), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0035633](http://purl.obolibrary.org/obo/GO_0035633) (maintenance of permeability of blood-brain barrier), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0090303](http://purl.obolibrary.org/obo/GO_0090303) (positive regulation of wound healing), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0006097](http://purl.obolibrary.org/obo/GO_0006097) (glyoxylate cycle), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0006099](http://purl.obolibrary.org/obo/GO_0006099) (tricarboxylic acid cycle), [GO:0008156](http://purl.obolibrary.org/obo/GO_0008156) (negative regulation of DNA replication), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0046825](http://purl.obolibrary.org/obo/GO_0046825) (regulation of protein export from nucleus), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0001878](http://purl.obolibrary.org/obo/GO_0001878) (response to yeast), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0030175](http://purl.obolibrary.org/obo/GO_0030175) (filopodium), [GO:0032357](http://purl.obolibrary.org/obo/GO_0032357) (oxidized purine DNA binding), [GO:0010224](http://purl.obolibrary.org/obo/GO_0010224) (response to UV-B), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007033](http://purl.obolibrary.org/obo/GO_0007033) (vacuole organization), [GO:0030295](http://purl.obolibrary.org/obo/GO_0030295) (protein kinase activator activity), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0045740](http://purl.obolibrary.org/obo/GO_0045740) (positive regulation of DNA replication), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0042475](http://purl.obolibrary.org/obo/GO_0042475) (odontogenesis of dentin-containing tooth), [GO:0007398](http://purl.obolibrary.org/obo/GO_0007398) (ectoderm development), [GO:0097150](http://purl.obolibrary.org/obo/GO_0097150) (neuronal stem cell population maintenance), [GO:0021697](http://purl.obolibrary.org/obo/GO_0021697) (cerebellar cortex formation), [GO:0001840](http://purl.obolibrary.org/obo/GO_0001840) (neural plate development), [GO:0043570](http://purl.obolibrary.org/obo/GO_0043570) (maintenance of DNA repeat elements), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:0001726](http://purl.obolibrary.org/obo/GO_0001726) (ruffle), [GO:0035855](http://purl.obolibrary.org/obo/GO_0035855) (megakaryocyte development), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0032228](http://purl.obolibrary.org/obo/GO_0032228) (regulation of synaptic transmission, GABAergic), [GO:0007043](http://purl.obolibrary.org/obo/GO_0007043) (cell-cell junction assembly), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0000406](http://purl.obolibrary.org/obo/GO_0000406) (double-strand/single-strand DNA junction binding), [GO:0031492](http://purl.obolibrary.org/obo/GO_0031492) (nucleosomal DNA binding), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0000404](http://purl.obolibrary.org/obo/GO_0000404) (heteroduplex DNA loop binding), [GO:0000403](http://purl.obolibrary.org/obo/GO_0000403) (Y-form DNA binding), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0000400](http://purl.obolibrary.org/obo/GO_0000400) (four-way junction DNA binding), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0008017](http://purl.obolibrary.org/obo/GO_0008017) (microtubule binding), [GO:0030275](http://purl.obolibrary.org/obo/GO_0030275) (LRR domain binding), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:0071902](http://purl.obolibrary.org/obo/GO_0071902) (positive regulation of protein serine/threonine kinase activity), [GO:0035441](http://purl.obolibrary.org/obo/GO_0035441) (cell migration involved in vasculogenesis), [GO:0007093](http://purl.obolibrary.org/obo/GO_0007093) (mitotic cell cycle checkpoint), [GO:0050839](http://purl.obolibrary.org/obo/GO_0050839) (cell adhesion molecule binding), [GO:0046579](http://purl.obolibrary.org/obo/GO_0046579) (positive regulation of Ras protein signal transduction), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0045128](http://purl.obolibrary.org/obo/GO_0045128) (negative regulation of reciprocal meiotic recombination), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0004935](http://purl.obolibrary.org/obo/GO_0004935) (adrenergic receptor activity), [GO:0048642](http://purl.obolibrary.org/obo/GO_0048642) (negative regulation of skeletal muscle tissue development), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:2000630](http://purl.obolibrary.org/obo/GO_2000630) (positive regulation of miRNA metabolic process), [GO:0035793](http://purl.obolibrary.org/obo/GO_0035793) (positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway), [GO:0032285](http://purl.obolibrary.org/obo/GO_0032285) (non-myelinated axon ensheathment), [GO:0035791](http://purl.obolibrary.org/obo/GO_0035791) (platelet-derived growth factor receptor-beta signaling pathway), [GO:0000228](http://purl.obolibrary.org/obo/GO_0000228) (nuclear chromosome), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0004702](http://purl.obolibrary.org/obo/GO_0004702) (signal transducer, downstream of receptor, with serine/threonine kinase activity), [GO:0003854](http://purl.obolibrary.org/obo/GO_0003854) (3-beta-hydroxy-delta5-steroid dehydrogenase activity), [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0071880](http://purl.obolibrary.org/obo/GO_0071880) (adenylate cyclase-activating adrenergic receptor signaling pathway), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0035789](http://purl.obolibrary.org/obo/GO_0035789) (metanephric mesenchymal cell migration), [GO:0004709](http://purl.obolibrary.org/obo/GO_0004709) (MAP kinase kinase kinase activity), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0032154](http://purl.obolibrary.org/obo/GO_0032154) (cleavage furrow), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0000795](http://purl.obolibrary.org/obo/GO_0000795) (synaptonemal complex), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0071670](http://purl.obolibrary.org/obo/GO_0071670) (smooth muscle cell chemotaxis), [GO:0050730](http://purl.obolibrary.org/obo/GO_0050730) (regulation of peptidyl-tyrosine phosphorylation), [GO:0001885](http://purl.obolibrary.org/obo/GO_0001885) (endothelial cell development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001886](http://purl.obolibrary.org/obo/GO_0001886) (endothelial cell morphogenesis), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:2000774](http://purl.obolibrary.org/obo/GO_2000774) (positive regulation of cellular senescence), [GO:0032389](http://purl.obolibrary.org/obo/GO_0032389) (MutLalpha complex), [GO:0010596](http://purl.obolibrary.org/obo/GO_0010596) (negative regulation of endothelial cell migration), [GO:0050852](http://purl.obolibrary.org/obo/GO_0050852) (T cell receptor signaling pathway), [GO:0032142](http://purl.obolibrary.org/obo/GO_0032142) (single guanine insertion binding), [GO:0032143](http://purl.obolibrary.org/obo/GO_0032143) (single thymine insertion binding), [GO:0046488](http://purl.obolibrary.org/obo/GO_0046488) (phosphatidylinositol metabolic process), [GO:0048545](http://purl.obolibrary.org/obo/GO_0048545) (response to steroid hormone), [GO:0090280](http://purl.obolibrary.org/obo/GO_0090280) (positive regulation of calcium ion import), [GO:0001894](http://purl.obolibrary.org/obo/GO_0001894) (tissue homeostasis), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0032135](http://purl.obolibrary.org/obo/GO_0032135) (DNA insertion or deletion binding), [GO:0032139](http://purl.obolibrary.org/obo/GO_0032139) (dinucleotide insertion or deletion binding), [GO:0032137](http://purl.obolibrary.org/obo/GO_0032137) (guanine/thymine mispair binding), [GO:0032138](http://purl.obolibrary.org/obo/GO_0032138) (single base insertion or deletion binding), [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0060842](http://purl.obolibrary.org/obo/GO_0060842) (arterial endothelial cell differentiation), [GO:0001588](http://purl.obolibrary.org/obo/GO_0001588) (dopamine neurotransmitter receptor activity, coupled via Gs), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0043274](http://purl.obolibrary.org/obo/GO_0043274) (phospholipase binding), [GO:0055003](http://purl.obolibrary.org/obo/GO_0055003) (cardiac myofibril assembly), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0034260](http://purl.obolibrary.org/obo/GO_0034260) (negative regulation of GTPase activity), [GO:0048609](http://purl.obolibrary.org/obo/GO_0048609) (multicellular organismal reproductive process), [GO:0048845](http://purl.obolibrary.org/obo/GO_0048845) (venous blood vessel morphogenesis), [GO:0045454](http://purl.obolibrary.org/obo/GO_0045454) (cell redox homeostasis), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0045216](http://purl.obolibrary.org/obo/GO_0045216) (cell-cell junction organization), [GO:0046426](http://purl.obolibrary.org/obo/GO_0046426) (negative regulation of JAK-STAT cascade), [GO:0005712](http://purl.obolibrary.org/obo/GO_0005712) (chiasma), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development), [GO:0060837](http://purl.obolibrary.org/obo/GO_0060837) (blood vessel endothelial cell differentiation), [GO:0003779](http://purl.obolibrary.org/obo/GO_0003779) (actin binding), [GO:0006807](http://purl.obolibrary.org/obo/GO_0006807) (nitrogen compound metabolic process), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0043044](http://purl.obolibrary.org/obo/GO_0043044) (ATP-dependent chromatin remodeling), [GO:0050921](http://purl.obolibrary.org/obo/GO_0050921) (positive regulation of chemotaxis), [GO:0060981](http://purl.obolibrary.org/obo/GO_0060981) (cell migration involved in coronary angiogenesis), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0046676](http://purl.obolibrary.org/obo/GO_0046676) (negative regulation of insulin secretion), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0045596](http://purl.obolibrary.org/obo/GO_0045596) (negative regulation of cell differentiation), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0004716](http://purl.obolibrary.org/obo/GO_0004716) (signal transducer, downstream of receptor, with protein tyrosine kinase activity), [GO:0033277](http://purl.obolibrary.org/obo/GO_0033277) (abortive mitotic cell cycle), [GO:0070306](http://purl.obolibrary.org/obo/GO_0070306) (lens fiber cell differentiation), [GO:0036302](http://purl.obolibrary.org/obo/GO_0036302) (atrioventricular canal development), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:0035335](http://purl.obolibrary.org/obo/GO_0035335) (peptidyl-tyrosine dephosphorylation), [GO:0035330](http://purl.obolibrary.org/obo/GO_0035330) (regulation of hippo signaling), [GO:0008094](http://purl.obolibrary.org/obo/GO_0008094) (DNA-dependent ATPase activity), [GO:0032181](http://purl.obolibrary.org/obo/GO_0032181) (dinucleotide repeat insertion binding), [GO:0042088](http://purl.obolibrary.org/obo/GO_0042088) (T-helper 1 type immune response), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0045597](http://purl.obolibrary.org/obo/GO_0045597) (positive regulation of cell differentiation), [GO:0060973](http://purl.obolibrary.org/obo/GO_0060973) (cell migration involved in heart development), [GO:0005811](http://purl.obolibrary.org/obo/GO_0005811) (lipid droplet), [GO:0043060](http://purl.obolibrary.org/obo/GO_0043060) (meiotic metaphase I plate congression), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0000252](http://purl.obolibrary.org/obo/GO_0000252) (C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0004726](http://purl.obolibrary.org/obo/GO_0004726) (non-membrane spanning protein tyrosine phosphatase activity), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0015616](http://purl.obolibrary.org/obo/GO_0015616) (DNA translocase activity), [GO:0008092](http://purl.obolibrary.org/obo/GO_0008092) (cytoskeletal protein binding), 

**Class expressions from DL-Learner:**

- Thing 58.48%
- [GO:0032550](http://purl.obolibrary.org/obo/GO_0032550) (purine ribonucleoside binding) 50.85%
- [GO:0001883](http://purl.obolibrary.org/obo/GO_0001883) (purine nucleoside binding) 50.85%
- [GO:0032550](http://purl.obolibrary.org/obo/GO_0032550) (purine ribonucleoside binding) and [GO:1901265](http://purl.obolibrary.org/obo/GO_1901265) (nucleoside phosphate binding) 50.85%
- [GO:0032550](http://purl.obolibrary.org/obo/GO_0032550) (purine ribonucleoside binding) and [GO:0043168](http://purl.obolibrary.org/obo/GO_0043168) (anion binding) 50.85%
- [GO:0032550](http://purl.obolibrary.org/obo/GO_0032550) (purine ribonucleoside binding) and [GO:0043167](http://purl.obolibrary.org/obo/GO_0043167) (ion binding) 50.85%
- [GO:0032550](http://purl.obolibrary.org/obo/GO_0032550) (purine ribonucleoside binding) and [GO:0032561](http://purl.obolibrary.org/obo/GO_0032561) (guanyl ribonucleotide binding) 50.85%
- [GO:0032550](http://purl.obolibrary.org/obo/GO_0032550) (purine ribonucleoside binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) 50.85%
- [GO:0032550](http://purl.obolibrary.org/obo/GO_0032550) (purine ribonucleoside binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) 50.85%
- [GO:0032549](http://purl.obolibrary.org/obo/GO_0032549) (ribonucleoside binding) and [GO:0032561](http://purl.obolibrary.org/obo/GO_0032561) (guanyl ribonucleotide binding) 50.85%
- [GO:0032549](http://purl.obolibrary.org/obo/GO_0032549) (ribonucleoside binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) 50.85%
- [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding) and [GO:0032550](http://purl.obolibrary.org/obo/GO_0032550) (purine ribonucleoside binding) 50.85%
- [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding) and [GO:0032549](http://purl.obolibrary.org/obo/GO_0032549) (ribonucleoside binding) 50.85%
- [GO:0017076](http://purl.obolibrary.org/obo/GO_0017076) (purine nucleotide binding) and [GO:0032550](http://purl.obolibrary.org/obo/GO_0032550) (purine ribonucleoside binding) 50.85%
- [GO:0017076](http://purl.obolibrary.org/obo/GO_0017076) (purine nucleotide binding) and [GO:0032549](http://purl.obolibrary.org/obo/GO_0032549) (ribonucleoside binding) 50.85%


